Procter & Gamble Company (The) $PG Stock Holdings Decreased by Ullmann Wealth Partners Group LLC

Ullmann Wealth Partners Group LLC reduced its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,707 shares of the company’s stock after selling 539 shares during the period. Ullmann Wealth Partners Group LLC’s holdings in Procter & Gamble were worth $2,821,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in PG. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp grew its position in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after purchasing an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after purchasing an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 0.7%

Shares of PG stock opened at $156.15 on Friday. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43. The stock has a market cap of $365.47 billion, a price-to-earnings ratio of 23.99, a P/E/G ratio of 4.12 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a fifty day moving average of $156.16 and a 200-day moving average of $161.28.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the prior year, the company posted $1.40 EPS. The business’s revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio is currently 64.82%.

Insider Buying and Selling

In other news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the sale, the chief executive officer directly owned 319,375 shares in the company, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 120,181 shares of company stock worth $18,918,012. Insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on PG. Barclays set a $164.00 target price on shares of Procter & Gamble and gave the stock an “equal weight” rating in a research report on Thursday, July 31st. Evercore ISI reissued an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company decreased their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. BNP Paribas reissued an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $173.94.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.